STRO: Bathi resik saben saham (EPS TTM) Sutro Bio

Sutro Biopharma, Inc. (STRO) is gradually depleting its existing capital to fund costly clinical trials. This rolling 12-month EPS chart illustrates the current trend, with the metric currently at -17.58. Strategic alliances with pharma behemoths provide cash inflows, stabilizing free cash flow. However, uncertainty regarding trial outcomes and the high capital intensity of development create certain financial risks.

STRO Bathi resik saben saham sajrone 12 wulan pungkasan Sutro Biopharma, Inc. (04.07.2022 - 13.11.2026)

Ringkesan rincian data analitis Sutro Biopharma Inc. (STRO)

- rega saham lan prakiraan rega para ahli:

Kutipan saham Sutro Biopharma, Inc.|STRO - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Kapitalisasi pasar Sutro Biopharma, Inc.|STRO - Rega Tumbas Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham Sutro Biopharma|STRO - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku sutrobio.com|STRO - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Rasio Total Utang marang Ekuitas Sutro Biopharma, Inc.|STRO - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Sutro Bio|STRO - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Sutro Biopharma, Inc.|STRO - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Sutro Biopharma|Indikator likuiditas cepet sutrobio.com

- data bathi lan kelipatan valuasi:

STRO - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Sutro Biopharma, Inc.|STRO - Nilai perusahaan marang bathi resik|Pangali Forward P/E Sutro Biopharma|STRO - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sutro Biopharma, Inc.|STRO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Sutro Biopharma|STRO - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sutrobio.com|STRO - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Sutro Biopharma, Inc.

Pambiji fundamental:STRO - Sutro Biopharma, Inc.

The calculation model for this indicator is highly sensitive to operational efficiency and actual business profitability. This metric determines the portion of net income attributable to a single common share over a rolling year. For Sutro Biopharma, Inc. (STRO), which develops high-precision oncotherapeutic conjugates, this serves as an indicator of the monetization of its scientific research. Analyzing the per-share profit trend over the last 12 months allows for the separation of speculative noise from fundamental performance.

Pesaing utama